North America Colorectal Procedure Market

The North America colorectal procedure market is expected to grow from US$ 6,311.66 million in 2022 to US$ 12,946.28 million by 2028. It is estimated to grow at a CAGR of 12.7% from 2022 to 2028.

Increasing Prevalence of Colorectal Cancer Fuel North America Colorectal Procedure Market

The market for colorectal procedures is ascribed to frequent diagnostic tests and medical device launches. Most of the major market players are involved in manufacturing a wide range of devices that help in reducing the burden of colorectal cancer and other associated indications such as colon polyps, Crohn’s disease, colitis, irritable bowel syndrome, and others. For instance, in April 2020, Olympus Corporation announced the launch of EVIS X1, which is the most advanced endoscopy. This system helps to improve the results from disorders of the stomach, colon, esophagus, and bronchial diseases. The system has various features such as extended depth of field (EDOF), red dichromatic imaging (RDI), texture and color enhancement imaging (TXI), and narrow-band imaging (NBI). The launch of EVIS X1 strengthened Olympus leadership in endoscopy and in the medical device industry.

 In July 2022, US Digestive Health (USDH), a network of top-rated gastrointestinal (GI) practices, announced the commercialization of AI-assisted colonoscopy screenings with the country’s largest installation of GI Genious Intelligent endoscopy modules. In real-time, it will help physicians identify hard-to-detect and potentially cancerous polyps. The launch of the device will give patients throughout southeastern, southwestern, and central Pennsylvania wide-ranging access to the innovative and its enhanced capability. Moreover, in September 2020, Olympus Corporation announced the launch of ENDO-AID, a cutting-edge platform powered by artificial intelligence (AI) and includes the endoscopy application ENDO-AID CADe (computer-aided detection) for the colon. This new AI platform enables the real-time display of automatically detected suspicious lesions and works in combination with the recently introduced EVIS X1. Thus, the constant developments and new product launches in colorectal-associated indications are driving the colorectal procedural market growth.

North America Colorectal Procedure Market Overview

The North America North America colorectal procedure market is segmented into the US, Canada, and Mexico. North America is the dominating region in the global colorectal procedure market. The growth can be attributed to age-related problems, increasing government funds, and continuous regional technology improvements. The growth of the North America colorectal procedure market in the region is expected to grow due to significantly rising incidences of colorectal cancer across the country and growing government support for the research in colon cancer. Moreover, the government provides multiple programs for the betterment of the population.

North America Colorectal Procedure Market Revenue and Forecast to 2028 (US$ Million)

North America Colorectal Procedure Strategic Insights

Strategic insights for the North America Colorectal Procedure provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Colorectal Procedure Report Scope

North America Colorectal Procedure Regional Insights

The geographic scope of the North America Colorectal Procedure refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Colorectal Procedure Market Segmentation

The North America colorectal procedure market is segmented into product, surgery type, indication, end user, and country.

Based on route of product, the North America colorectal procedure market is segmented into endoscope, electrosurgery, handheld devices and visual systems, sealing and stapling devices, ligation clips and dilators and speculas, cutter and shears, accessories, and others. The endoscope segment held the largest share of the North America colorectal procedure market in 2022.

Based on surgery type, the North America colorectal procedure market is segmented into right hemicolectomy, left hemicolectomy, subtotal colectomy, low anterior resection, abdomino-perineal resection, and others (including endoscopic surgery). The subtotal colectomy segment held the largest share of the North America colorectal procedure market in 2022.

Based on end user, the North America colorectal procedure market is segmented into hospitals & clinics, surgery centers, and others. The hospitals and clinics segment held the largest share of the North America colorectal procedure market in 2022.

Based on indication, the North America colorectal procedure market is segmented into colon polyps, Crohn's disease, colorectal cancer, colitis, irritable bowel syndrome, and other indications. The irritable bowel syndrome segment held the largest share of the North America colorectal procedure market in 2022.

Based on country, the North America colorectal procedure market is segmented into US, Canada, and Mexico. US dominated the North America colorectal procedure market in 2022.   

Ethicon (Johnson & Johnson Services, Inc.); Medtronic; Colospan Ltd; SAFEHEAL; B. Braun Melsungen; Cardinal Health Inc; Boston Scientific Corporation; CooperSurgical, Inc; Olympus Corporation are some of the leading companies operating in the North America colorectal procedure market.